131 related articles for article (PubMed ID: 38394846)
1. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
4. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer.
Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L
Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809
[TBL] [Abstract][Full Text] [Related]
5. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
8. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
[TBL] [Abstract][Full Text] [Related]
10. Multiple genetic alterations in small-cell lung carcinoma.
Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
[TBL] [Abstract][Full Text] [Related]
11. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
Geradts J; Fong KM; Zimmerman PV; Minna JD
Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal localization of putative tumor-suppressor genes in several human cancers.
Yokota J; Sugimura T; Terada M
Environ Health Perspect; 1991 Jun; 93():121-3. PubMed ID: 1685440
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
14. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
[TBL] [Abstract][Full Text] [Related]
15. Allelotype of non-small cell lung cancer.
Neville E; Stewart M; Swift A; Liloglou T; Ross H; Gosney J; Donnelly R; Field J
Int J Oncol; 1996 Sep; 9(3):533-9. PubMed ID: 21541547
[TBL] [Abstract][Full Text] [Related]
16. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types.
Virmani AK; Fong KM; Kodagoda D; McIntire D; Hung J; Tonk V; Minna JD; Gazdar AF
Genes Chromosomes Cancer; 1998 Apr; 21(4):308-19. PubMed ID: 9559342
[TBL] [Abstract][Full Text] [Related]
17. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
Li L; An Q; Feng X
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
